AlphaStocks

AZN vs LIF

ASTRAZENECA PLC vs Life360, Inc. — Side-by-Side Stock Comparison

AZN

ASTRAZENECA PLC

8.4

Strong Buy

$200.99

LIF

Life360, Inc.

2.2

Avoid

$41.22

AZN vs LIF: Which is the Better Investment?

ASTRAZENECA PLC (AZN) scores 8.4/10 while Life360, Inc. (LIF) scores 2.2/10 on AlphaStocks' composite model. ASTRAZENECA PLC has the higher composite rating of Strong Buy. On a P/E basis, Life360, Inc. trades at 23.3x, making it the more attractively priced of the two.

This comparison is algorithmically generated and is not financial advice.

MetricAZNLIF
Scores & Fundamentals
Composite Score8.4/102.2/10
RatingStrong BuyAvoid
Price$200.99$41.22
P/E Ratio30.423.3
ROE21.9%22.4%
Market Cap$312B$4B
Fair Value$192.63
Dividend Yield1.6%
Sector Rank#3 of 1127#1078 of 1127
Model Verdicts
PiotroskiStrongAttractive
BuffettStrongNeutral
GrahamCautionCaution
LynchNeutralLimited Data
GreenblattNeutralLimited Data
View full AZNanalysis →View full LIFanalysis →
Compare any two stocks →

AZN vs LIF: Which Stock Scores Higher?

ASTRAZENECA PLC (AZN) and Life360, Inc. (LIF) are among the most compared stocks in the S&P 500. AZN currently leads with a composite score of 8.4/10 (Strong Buy) compared to LIF's 2.2/10 (Avoid).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer